MENU
MDNAF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Medicenna Therapeutics (MDNAF) Ownership - Who owns Medicenna Therapeutics?
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company... Show more
Profile
Industry
N/A
Address
2 Bloor Street W.
Phone
+1 416 648-5555
Employees
16
Web
https://www.medicenna.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
61.63M
P/E Ratio
N/A
Total Cash
30M
Projected Growth
N/A
Total Debt
174K
Revenue
N/A
Risk (Beta)
2.78
Dividend Yield
N/A
Total Cash/Share
0.38
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MDNAF
Capitalization
61.6M
P/E Ratio
N/A
Risk (Beta)
2.78
Dividend Yield
N/A
Total Cash
30M
Total Cash/Share
0.38
Total Debt
174K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
17.5M
P/B Ratio
5.13
Cash Flow
N/A
Earnings
-0.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
116M
Current Ratio
10.09
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-18.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-96.91
Shares Held By Institutions
200K
Shares Outstanding - Current
78.2M
Total Liabilities
14.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-28.384
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2 Bloor Street W.
Phone
+1 416 648-5555
Employees
16
Web
https://www.medicenna.com